|
|
Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg−/− mice |
Yaqin Du1, Ting Wang1, Jun Xu1, Chaoran Zhao1, Haibo Li1, Yao Fu3, Yaxing Xu2, Liangfu Xie3, Jingru Zhao2, Weifeng Yang4, Ming Yin4, Jinhua Wen1( ), Hongkui Deng1,2,3( ) |
1. Peking University Stem Cell Research Center, Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China 2. Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, College of Life Sciences, Peking University, Beijing 100871, China 3. The MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China 4. Beijing Vitalstar Biotechnology, Beijing 100012, China |
|
|
Abstract Recently we have established a new culture condition enabling the derivation of extended pluripotent stem (EPS) cells, which, compared to conventional pluripotent stem cells, possess superior developmental potential and germline competence. However, it remains unclear whether this condition permits derivation of EPS cells from mouse strains that are refractory or non-permissive to pluripotent cell establishment. Here, we show that EPS cells can be robustly generated from non-permissive NOD-scid Il2rg−/− mice through de novo derivation from blastocysts. Furthermore, these cells can also be efficiently generated by chemical reprogramming from embryonic NOD-scid Il2rg−/− fibroblasts. NOD-scid Il2rg−/− EPS cells can be expanded for more than 20 passages with genomic stability and can be genetically modified through gene targeting. Notably, these cells contribute to both embryonic and extraembryonic lineages in vivo. More importantly, they can produce chimeras and integrate into the E13.5 genital ridge. Our study demonstrates the feasibility of generating EPS cells from refractory mouse strains, which could potentially be a general strategy for deriving mouse pluripotent cells. The generation of NOD-scid Il2rg−/− EPS cell lines permits sophisticated genetic modification in NOD-scid Il2rg−/− mice, which may greatly advance the optimization of humanized mouse models for biomedical applications.
|
Keywords
extended pluripotent stem cell
NOD-scid Il2rg−/− mice
embryonic and extraembryonic lineages
chemical reprogramming
|
Corresponding Author(s):
Jinhua Wen,Hongkui Deng
|
Issue Date: 31 January 2019
|
|
1 |
PDAnderson, VRNelson, PJTesar, JHNadeau (2009) Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation. Cancer Res 69:9112–9117
https://doi.org/10.1158/0008-5472.CAN-09-3342
|
2 |
TBrambrink, RForeman, GGWelstead, CJLengner, MWernig, HSuh, RJaenisch (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2:151–159
https://doi.org/10.1016/j.stem.2008.01.004
|
3 |
FABrook, EPEvans, CJLord, PALyons, DBRainbow, SKHowlett, LSWicker, JATodd, RLGardner (2003) The derivation of highly germline-competent embryonic stem cells containing NODderived genome. Diabetes 52:205–208
https://doi.org/10.2337/diabetes.52.1.205
|
4 |
FABrook, RLGardner (1997) The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci USA 94:5709–5712
https://doi.org/10.1073/pnas.94.11.5709
|
5 |
VBryja, SBonilla, EArenas (2006a) Derivation of mouse embryonic stem cells. Nat Protoc 1:2082–2087
https://doi.org/10.1038/nprot.2006.355
|
6 |
VBryja, SBonilla, LCajanek, CLParish, CMSchwartz, YLuo, MSRao, EArenas (2006b) An efficient method for the derivation of mouse embryonic stem cells. Stem Cells 24:844–849
https://doi.org/10.1634/stemcells.2005-0444
|
7 |
MBuehr, ASmith (2003) Genesis of embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 358:1397–1402discussion 1402
https://doi.org/10.1098/rstb.2003.1327
|
8 |
JChoi, AJHuebner, KClement, RMWalsh, ASavol, KLin, HGu, BDi Stefano, JBrumbaugh, SYKimet al. (2017) Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. Nature 548:219–223
https://doi.org/10.1038/nature23274
|
9 |
MJEvans, MHKaufman (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
https://doi.org/10.1038/292154a0
|
10 |
JHanna, SMarkoulaki, MMitalipova, AWCheng, JPCassady, JStaerk, BWCarey, CJLengner, RForeman, JLoveet al. (2009) Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4:513–524
https://doi.org/10.1016/j.stem.2009.04.015
|
11 |
PHou, YLi, XZhang, CLiu, JGuan, HLi, TZhao, JYe, WYang, KLiuet al. (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651–654
https://doi.org/10.1126/science.1239278
|
12 |
MIto, HHiramatsu, KKobayashi, KSuzue, MKawahata, KHioki, YUeyama, YKoyanagi, KSugamura, KTsujiet al. (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182
https://doi.org/10.1182/blood-2001-12-0207
|
13 |
RIto, TTakahashi, IKatano, MIto (2012) Current advances in humanized mouse models. Cell Mol Immunol 9:208–214
https://doi.org/10.1038/cmi.2012.2
|
14 |
EKawase, HSuemori, NTakahashi, KOkazaki, KHashimoto, NNakatsuji (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int J Dev Biol 38:385–390
|
15 |
KLiu, RFang, HLi, WYang, ZMiao, JWen, HDeng (2015) Efficient derivation of embryonic stem cells from NOD-scid Il2rg−/− mice. Protein Cell 6:916–918
https://doi.org/10.1007/s13238-015-0209-6
|
16 |
PLodge, JMcWhir, EGallagher, HSang (2005) Increased gp130 signaling in combination with inhibition of the MEK/ERK pathway facilitates embryonic stem cell isolation from normally refractory murine CBA blastocysts. Cloning Stem Cells 7:2–7
https://doi.org/10.1089/clo.2005.7.2
|
17 |
GRMartin (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634–7638
https://doi.org/10.1073/pnas.78.12.7634
|
18 |
JMcWhir, AESchnieke, RAnsell, HWallace, AColman, ARScott, AJKind (1996) Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat Genet 14:223–226
https://doi.org/10.1038/ng1096-223
|
19 |
SNagafuchi, HKatsuta, KKogawa, TAkashi, SKondo, YSakai, TTsukiyama, DKitamura, YNiho, TWatanabe (1999) Establishment of an embryonic stem (ES) cell line derived from a nonobese diabetic (NOD) mouse: in vivo differentiation into lymphocytes and potential for germ line transmission. FEBS Lett 455:101–104
https://doi.org/10.1016/S0014-5793(99)00801-7
|
20 |
JNichols, KJones, JMPhillips, SANewland, MRoode, WMansfield, ASmith, ACooke (2009) Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med 15:814–818
https://doi.org/10.1038/nm.1996
|
21 |
KOkita, MNakagawa, HHyenjong, TIchisaka, SYamanaka (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949–953
https://doi.org/10.1126/science.1164270
|
22 |
SPicelli, ORFaridani, AKBjorklund, GWinberg, SSagasser, RSandberg (2014) Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc 9:171–181
https://doi.org/10.1038/nprot.2014.006
|
23 |
LDShultz, FIshikawa, DLGreiner (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118–130
https://doi.org/10.1038/nri2017
|
24 |
LDShultz, BLLyons, LMBurzenski, BGott, XChen, SChaleff, MKotb, SDGillies, MKing, JMangadaet al. (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477–6489
https://doi.org/10.4049/jimmunol.174.10.6477
|
25 |
MStadtfeld, MNagaya, JUtikal, GWeir, KHochedlinger (2008) Induced pluripotent stem cells generated without viral integration. Science 322:945–949
https://doi.org/10.1126/science.1162494
|
26 |
KTakahashi, SYamanaka (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
https://doi.org/10.1016/j.cell.2006.07.024
|
27 |
HUmehara, TKimura, SOhtsuka, TNakamura, KKitajima, MIkawa, MOkabe, HNiwa, TNakano (2007) Efficient derivation of embryonic stem cells by inhibition of glycogen synthase kinase-3. Stem Cells 25:2705–2711
https://doi.org/10.1634/stemcells.2007-0086
|
28 |
KWoltjen, IPMichael, PMohseni, RDesai, MMileikovsky, RHamalainen, RCowling, WWang, PLiu, MGertsensteinet al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766–770
https://doi.org/10.1038/nature07863
|
29 |
MYagi, SKishigami, ATanaka, KSemi, EMizutani, SWakayama, TWakayama, TYamamoto, YYamada (2017) Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation. Nature 548:224–227
https://doi.org/10.1038/nature23286
|
30 |
WYang, WWei, CShi, JZhu, WYing, YShen, XYe, LFang, SDuo, JCheet al. (2009) Pluripotin combined with leukemia inhibitory factor greatly promotes the derivation of embryonic stem cell lines from refractory strains. Stem Cells 27:383–389
https://doi.org/10.1634/stemcells.2008-0974
|
31 |
YYang, BLiu, JXu, JWang, JWu, CShi, YXu, JDong, CWang, WLaiet al. (2017) Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency. Cell 169(243–257):e225
https://doi.org/10.1016/j.cell.2017.02.005
|
32 |
JYe, JGe, XZhang, LCheng, ZZhang, SHe, YWang, HLin, WYang, JLiuet al. (2016) Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Cell Res 26:34–45
https://doi.org/10.1038/cr.2015.142
|
33 |
QLYing, JNichols, IChambers, ASmith (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281–292
https://doi.org/10.1016/S0092-8674(03)00847-X
|
34 |
QLYing, JWray, JNichols, LBatlle-Morera, BDoble, JWoodgett, PCohen, ASmith (2008) The ground state of embryonic stem cell self-renewal. Nature 453:519–523
https://doi.org/10.1038/nature06968
|
35 |
HYu, CBorsotti, JNSchickel, SZhu, TStrowig, EEEynon, DFrleta, CGurer, AJMurphy, GDYancopouloset al. (2017) A novel humanized mouse model with significant improvement of classswitched, antigen-specific antibody production. Blood 129:959–969
https://doi.org/10.1182/blood-2016-04-709584
|
36 |
YZhao, TZhao, JGuan, XZhang, YFu, JYe, JZhu, GMeng, JGe, SYanget al. (2015) A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming. Cell 163:1678–1691
https://doi.org/10.1016/j.cell.2015.11.017
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|